// App-Quantinova.ai

THU0122 : SAFETY OF SURGERY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED BY RITUXIMAB IN ROUTINE CARE: DATA FROM THE FRENCH AIR REGISTRY

Researchers

Presenter

  • S. Godot

Principal Investigators

  • J.E. Gottenberg

  • S. Paternotte

  • X. Mariette

  • D. Wendling

  • J. Sellam

  • I. Pane

  • B. Combe

  • J. Sibilia

  • R.M. Flipo

  • T. Schaeverbeke

  • P. Ravaud

  • E. Toussirot

  • F. Berenbaum

Medical Centers

  • Rhumatologie, Hopital Saint Antoine, APHP, Universite Paris VI, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Deep vein thrombosis

  • Rheumatoid arthritis

  • Venous thrombosis

  • Septic shock

  • Inflammatory Arthritis

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved